Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease.
Research paper by
William W Reginold, Sarah S Duff-Canning, Christopher C Meaney, Melissa J MJ Armstrong, Susan S Fox, Brandon B Rothberg, Cindy C Zadikoff, Nancy N Kennedy, David D Gill, Paul P Eslinger, Fred F Marshall, Mark M Mapstone, Kelvin L KL Chou, Carol C Persad, Irene I Litvan, Benjamin B Mast, David D Tang-Wai, Anthony E AE Lang, Connie C Marras
To assess the impact of mild cognitive impairment (MCI) or cognitive decline on health-related quality of life (HR-QOL) in Parkinson's disease (PD).HR-QOL measured by the Parkinson Disease Quality of Life Questionnaire (PDQ-39), MCI according to Movement Disorder Society Task Force criteria and cognitive decline from premorbid baseline were assessed in non-demented PD patients at 6 movement disorder clinics.Among 137 patients, after adjusting for education, gender, disease duration, and Movement Disorder Society Unified Parkinson's Disease Rating Scale total score, MCI was associated with worse scores within the PDQ-39 dimension of communication (p = 0.008). Subjects were divided into tertiles of cognitive decline from premorbid level. Scores in the dimension of stigma were worst in the second tertile of cognitive decline (p = 0.03). MCI was associated with worse social support scores in the second tertile of cognitive decline (p = 0.008).MCI and cognitive decline from premorbid baseline are associated with reduced HR-QOL in communication, stigma, and social support domains. The cognitive decline from premorbid baseline modifies the association between MCI and HR-QOL in PD and knowing both will allow a better appreciation of difficulties patients face in daily life.